Think of it as a presidential Labor Day gift. The AP:
Researchers say workers are paying a larger portion of health insurance costs as businesses, trying to ride out the economic downturn, shift more of the burden to their employees.
Total premiums rose a modest 3 percent for family coverage and 5 percent for single employees. But Kaiser Family Foundation CEO Drew Altman said companies passed most of those increases on to workers instead of absorbing them as they usually do.
Well this certainly isn’t good:
A new poll shows that public support for health care reform dropped sharply in August — a dagger in Democrats’ hopes that their landmark legislation will help them in November’s midterm.
The Kaiser Health Tracking Poll has support for the bill dropping 7 percentage points in August — down to 43 percent — while opposition rose 10 points to 45 percent. That’s the weakest showing since May — and a far cry from the bump proponents had hoped to see as some of the law’s more consumer-friendly provisions kick in.
For the sake of argument, let’s speculate why this may be happening:
Can’t say I blame those polled.
This can’t be good for Democrats rolling into midterms. Maybe that’s why they’re being encouraged not to mention it.
Support for repeal of the health care reform bill is at its highest level in over a month, while the number of voters who believe repeal will be good for the economy has reached a new high.
The latest Rasmussen Reports national telephone survey of Likely Voters shows that 60% at least somewhat favor repeal of the health care reform law, while 36% oppose repeal.
Those numbers include 50% who Strongly Favor repeal and 26% who Strongly Oppose it.
Honestly, how did you think coverage was going to be extended to millions while maintaining the facade of low up-front cost? “Editing” or rationing services is the only way. Of course, they still haven’t found a way to actually fund the IRS to do what the bill says and they’ve also forgotten our children with this bill. Let’s go for three.
From Big Government:
In September, the Food and Drug Administration will try to take the anti-cancer drug Avastin “off-label.” Avastin is a Stage 4 drug used to battle breast cancer. Avastin is not a cure but has been shown to stop the growth of cancer for an average of five months — meaning some late stage breast cancer victims live beyond five months.
But late stage breast cancer patients do not fit into the cost-benefit analysis of the Obama Administration. We told America rationing would happen if the health care takeover bill passed and in September, women with breast cancer will be its first victims.
… this year they changed the mammography standard from 40 to 50, which could result in millions of women going undiagnosed.
Where is the outrage? Where are the feminists on this one?